Series of cisplatin prodrugs to inhibit fatty acid oxidation in prostate cancer

被引：0
|
作者：
Kalathil, Akil [1 ]
Dhar, Shanta [1 ]
机构：
[1] Univ Miami, Biochem & Mol Biol, Miami, FL USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
249
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Targeted prodrugs to manipulate copper biology of prostate cancer
    Bakthavatsalam, Subha
    Zhang, Tian
    Franz, Katherine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [42] Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo
    Gonzalez-Moreno, Oscar
    Segura, Victor
    Serrano, Diego
    Nguewa, Paul
    Rivas, Javier de las
    Calvo, Alfonso
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (06) : 1197 - 1204
  • [43] Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs
    Ravera, Mauro
    Gabano, Elisabetta
    Zanellato, Ilaria
    Fregonese, Federico
    Pelosi, Giorgio
    Platts, James A.
    Osella, Domenico
    DALTON TRANSACTIONS, 2016, 45 (12) : 5300 - 5309
  • [44] Evaluation of salicylic acid fatty ester prodrugs for UV protection
    Im, Jong Seob
    Balakrishnan, Prabagar
    Oh, Dong Hoon
    Kim, Jung Sun
    Jeon, Eun-Mi
    Kim, Dae-Duk
    Yong, Chul Soon
    Choi, Han-Gon
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2011, 37 (07) : 841 - 848
  • [45] Alkyl chain mobility and structure of crystalline fatty acid prodrugs
    Sanrame, Carlos N.
    Zeidan, Tarek A.
    Remenar, Julius F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [46] Tunable self-assembly of Irinotecan-fatty acid prodrugs with increased cytotoxicity to cancer cells
    Zhang, Chunqiu
    Jin, Shubin
    Xue, Xiangdong
    Zhang, Tingbin
    Jiang, Yonggang
    Wang, Paul C.
    Liang, Xing-Jie
    JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (19) : 3286 - 3291
  • [47] Cisplatin-encapsulated nanoparticles inhibit prostate tumor progression via cancer cell-specific targeting
    Singh, Rajesh
    Singh, Shailesh
    Singh, Udai P.
    Lillard, James W., Jr.
    CANCER RESEARCH, 2006, 66 (08)
  • [48] Evaluation of the fatty acid synthase inhibitor triclosan in prostate cancer cells
    Sadowski, Martin
    Pouwer, Rebecca
    Lubik, Amy
    McPherson, Stephen
    Nelson, Colleen
    BJU INTERNATIONAL, 2013, 112 : 42 - 42
  • [49] Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
    Migita, Toshiro
    Ruiz, Stacey
    Fornari, Alessandro
    Fiorentino, Michelangelo
    Priolo, Carmen
    Zadra, Giorgia
    Inazuka, Fumika
    Grisanzio, Chiara
    Palescandolo, Emanuele
    Shin, Eyoung
    Fiore, Christopher
    Xie, Wanling
    Kung, Andrew L.
    Febbo, Phillip G.
    Subramanian, Aravind
    Mucci, Lorelei
    Ma, Jing
    Signoretti, Sabina
    Stampfer, Meir
    Hahn, William C.
    Finn, Stephen
    Loda, Massimo
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (07): : 519 - 532
  • [50] Selective activation of the fatty acid synthesis pathway in human prostate cancer
    Swinnen, JV
    Vanderhoydonc, F
    Elgamal, AA
    Eelen, M
    Vercaeren, I
    Joniau, S
    Van Poppel, H
    Baert, L
    Goossens, K
    Heyns, W
    Verhoeven, G
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (02) : 176 - 179
12345